Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2013, Article ID 314292, 5 pages
http://dx.doi.org/10.1155/2013/314292
Case Report

Successful Treatment of Recurrent Primary Sclerosing Cholangitis after Orthotopic Liver Transplantation with Oral Vancomycin

1Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA 95762, USA
2Yale University, New Haven, CT 06510, USA
3Department of Pathology, Sutter Medical Center, Sacramento, CA 95816, USA
4Department of Pediatrics, Lucile Packard Children’s Hospital, Stanford University, Palo Alto, CA 94304, USA

Received 24 December 2012; Accepted 22 January 2013

Academic Editors: A. Beiras-Fernandez and J. Kaneko

Copyright © 2013 Yinka K. Davies et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Wee, J. Ludwig, and R. J. Coffey, “Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis,” Human Pathology, vol. 16, no. 7, pp. 719–726, 1985. View at Google Scholar · View at Scopus
  2. C. B. Rosen, D. M. Nagorney, R. H. Wiesner, R. J. Coffey, and N. F. LaRusso, “Cholangiocarcinoma complicating primary sclerosing cholangitis,” Annals of Surgery, vol. 213, no. 1, pp. 21–25, 2001. View at Google Scholar · View at Scopus
  3. J. M. Farrant, K. M. Hayllar, M. L. Wilkinson et al., “Natural history and prognostic variables in primary sclerosing cholangitis,” Gastroenterology, vol. 100, no. 6, pp. 1710–1717, 1991. View at Google Scholar · View at Scopus
  4. U. Broomé, R. Olsson, L. Lööf et al., “Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis,” Gut, vol. 38, no. 4, pp. 610–615, 1996. View at Google Scholar · View at Scopus
  5. C. Y. Ponsioen, S. M. E. Vrouenraets, W. Prawirodirdjo et al., “Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population,” Gut, vol. 51, no. 4, pp. 562–566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. J. W. Tischendorf, P. N. Meier, C. Stabburg et al., “Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis,” Scandinavian Journal of Gastroenterology, vol. 41, pp. 1227–1234, 2000. View at Google Scholar
  7. J. J. W. Tischendorf, H. Hecker, M. Kruger, M. P. Manns, and P. N. Meier, “Characterization, outcome and prognosis in 273 patients with primary sclerosing cholangitis,” The New England Journal of Medicine, vol. 310, pp. 899–903, 1984. View at Google Scholar
  8. R. H. Wiesner, P. M. Grambsch, E. R. Dickson et al., “Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis,” Hepatology, vol. 10, no. 4, pp. 430–436, 1989. View at Google Scholar · View at Scopus
  9. R. Olsson, A. Danielsson, G. Jarnerot et al., “Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis,” Gastroenterology, vol. 100, no. 5, pp. 1319–1323, 1991. View at Google Scholar · View at Scopus
  10. K. M. Abu-Elmagd, M. Malinchoc, E. R. Dickson et al., “Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis,” Surgery Gynecology and Obstetrics, vol. 177, no. 4, pp. 335–344, 1993. View at Google Scholar · View at Scopus
  11. K. M. Abu-Elmagd, R. Selby, S. Iwatsuki et al., “Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation,” Transplantation Proceedings, vol. 25, no. 1, pp. 1124–1125, 1993. View at Google Scholar · View at Scopus
  12. B. Nashan, H. J. Schlitt, G. Tusch et al., “Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation,” Hepatology, vol. 23, no. 5, pp. 1105–1111, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Brandsaeter, H. Isoneimi, U. Broome et al., “Liver transplantation for primary sclerosing cholangitis, predictors and consequences of hepatobiliary malignancy,” Journal of Hepatology, vol. 40, pp. 815–822, 2004. View at Google Scholar
  14. R. Chapman, J. Fevery, A. Kalloo et al., “Diagnosis and management of primary sclerosing cholangitis,” Hepatology, vol. 51, no. 2, pp. 660–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. L. Nikolaidis, O. I. Giouleme, K. A. Tziomalos et al., “Small-duct primary sclerosing cholangitis: a single-center seven-year experience,” Digestive Diseases and Sciences, vol. 50, no. 2, pp. 324–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Feldstein, J. Perrault, M. El-Youssif, K. D. Lindor, D. K. Freese, and P. Angulo, “Primary sclerosing cholangitis in children: a long-term follow-up study,” Hepatology, vol. 38, no. 1, pp. 210–217, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Mieli-Vergani and D. Vergani, “Unique features of primary sclerosing cholangitis in children,” Current Opinion in Gastroenterology, vol. 26, no. 3, pp. 265–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. L. Cox and K. M. Cox, “Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 27, no. 5, pp. 580–583, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. K. Davies, K. M. Cox, B. A. Abdullah, A. Safta, A. B. Terry, and K. L. Cox, “Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic,” Journal of Pediatric Gastroenterology and Nutrition, vol. 47, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Siedlar, A. Szczepanik, J. Wiȩckiewicz, A. Pituch-Noworolska, and M. Zembala, “Vancomycin down-regulates lipopolysaccharide-induced tumour necrosis factor alpha (TNFα) production and TNFα-mRNA accumulation in human blood monocytes,” Immunopharmacology, vol. 35, no. 3, pp. 265–271, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Di Febo, C. Calabrese, and F. Matassoni, “New trends in non-absorbable antibiotics in gastrointestinal disease,” Italian Journal of Gastroenterology, vol. 24, no. 9, pp. 10–13, 1992. View at Google Scholar · View at Scopus